Suppr超能文献

植物分子制药中宿主植物以及表达盒的结构与功能的最新进展

Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming.

作者信息

Makhzoum Abdullah, Benyammi Roukia, Moustafa Khaled, Trémouillaux-Guiller Jocelyne

出版信息

BioDrugs. 2014 Apr;28(2):145-59. doi: 10.1007/s40259-013-0062-1.

Abstract

Plant molecular pharming is a promising system to produce important recombinant proteins such as therapeutic antibodies, pharmaceuticals, enzymes, growth factors, and vaccines. The system provides an interesting alternative method to the direct extraction of proteins from inappropriate source material while offering the possibility to overcome problems related to product safety and source availability. Multiple factors including plant hosts, genes of interest, expression vector cassettes, and extraction and purification techniques play important roles in the plant molecular pharming. Plant species, as a biosynthesis platform, are a crucial factor in achieving high yields of recombinant protein in plant. The choice of recombinant gene and its expression strategy is also of great importance in ensuring a high amount of the recombinant proteins. Many studies have been conducted to improve expression, accumulation, and purification of the recombinant protein from molecular pharming systems. Re-engineered vectors and expression cassettes are also pivotal tools in enhancing gene expression at the transcription and translation level, and increasing protein accumulation, stability, retention and targeting of specific organelles. In this review, we report recent advances and strategies of plant molecular pharming while focusing on the choice of plant hosts and the role of some molecular pharming elements and approaches: promoters, codon optimization, signal sequences, and peptides used for upstream design, purification and downstream processing.

摘要

植物分子制药是一种很有前景的系统,可用于生产重要的重组蛋白,如治疗性抗体、药物、酶、生长因子和疫苗。该系统为从不合适的原料中直接提取蛋白质提供了一种有趣的替代方法,同时有可能克服与产品安全性和原料可用性相关的问题。包括植物宿主、目标基因、表达载体盒以及提取和纯化技术在内的多个因素在植物分子制药中起着重要作用。植物物种作为生物合成平台,是在植物中实现重组蛋白高产的关键因素。重组基因及其表达策略的选择对于确保大量重组蛋白的产生也非常重要。已经进行了许多研究来改善从分子制药系统中重组蛋白的表达、积累和纯化。重新设计的载体和表达盒也是在转录和翻译水平增强基因表达、增加蛋白质积累、稳定性、保留和靶向特定细胞器的关键工具。在本综述中,我们报告了植物分子制药的最新进展和策略,同时重点关注植物宿主的选择以及一些分子制药元件和方法的作用:启动子、密码子优化、信号序列以及用于上游设计、纯化和下游加工的肽。

相似文献

3
Molecular farming on rescue of pharma industry for next generations.分子农业拯救制药业的下一代。
Crit Rev Biotechnol. 2016 Oct;36(5):840-50. doi: 10.3109/07388551.2015.1049934. Epub 2015 Jun 4.
4
Transgenic rice endosperm as a bioreactor for molecular pharming.转基因水稻胚乳作为分子制药的生物反应器。
Plant Cell Rep. 2014 Apr;33(4):585-94. doi: 10.1007/s00299-013-1559-2. Epub 2014 Jan 12.
5
Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals.工程植物分泌途径生产新一代药物。
Trends Biotechnol. 2020 Sep;38(9):1034-1044. doi: 10.1016/j.tibtech.2020.03.004. Epub 2020 Apr 1.
8
Plant molecular pharming 2012 and beyond.2012年及以后的植物分子制药
Plant Cell Rep. 2012 Mar;31(3):437-8. doi: 10.1007/s00299-012-1227-y.

引用本文的文献

4
Recent Progress on Vaccines Produced in Transgenic Plants.转基因植物生产疫苗的最新进展
Vaccines (Basel). 2022 Nov 3;10(11):1861. doi: 10.3390/vaccines10111861.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验